The calcineurin protein phosphatase is dispensable for BCR-ABL-induced B-ALL maintenance, propagation and response to dasatinib

Leukemia. 2017 Jan;31(1):248-251. doi: 10.1038/leu.2016.269. Epub 2016 Oct 3.

Authors

F Rocchetti^{1

2}, C Tran Quang^{1

2}, A L Maragno^{1

2}, J Nguyen^{1

2}, C Lasgi³, J Ghysdael^{1

2}

Affiliations

¹ Institut Curie, PSL Research University, Orsay, France.
² Université Paris Sud, Université Paris-Saclay, Orsay, France.
³ Institut Curie, Plateforme Cytométrie, Orsay, France.

PMID: 27694923
DOI: 10.1038/leu.2016.269

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Calcineurin / pharmacology*
Cyclosporine / therapeutic use
Dasatinib / pharmacology*
Dasatinib / therapeutic use
Disease Models, Animal
Leukemia, B-Cell / drug therapy
Leukemia, B-Cell / pathology*
Mice
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology

Substances

Cyclosporine
Calcineurin
Dasatinib